Bharat Parenterals Ltd
BSE: 541096
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 41.41-0.7% | 41.70-55.8% | 94.37+17.6% | 80.28+19.2% | 67.34+4.5% | 64.45 |
| Other Income | 2.28-45.9% | 4.21+159.9% | 1.62-28.3% | 2.26-40.4% | 3.79-17.6% | 4.60 |
| Total Income | 43.69-4.8% | 45.91-52.2% | 95.99+16.3% | 82.54+16.0% | 71.13+3.0% | 69.05 |
| EXPENSES | ||||||
| Expenditure | 40.59-4.5% | 42.49-48.6% | 82.59+4.6% | 78.98+26.9% | 62.26+1.4% | 61.42 |
| Tax | 1.18+71.2% | 0.69-79.7% | 3.40+209.1% | 1.10-53.6% | 2.37+10.7% | 2.14 |
| PROFIT | ||||||
| PBT | 3.10-9.4% | 3.42-74.5% | 13.40+276.4% | 3.56-59.9% | 8.87+16.3% | 7.63 |
| Net Profit | 1.92-29.8% | 2.73-72.7% | 10.00+338.6% | 2.28-64.9% | 6.50+18.4% | 5.49 |
| KEY METRICS | ||||||
| OPM % | 8.38%+2.77pp | 5.61%-10.56pp | 16.17%+10.44pp | 5.73%+3.04pp | 2.69%+2.07pp | 0.62% |
| NPM % | 4.38%-1.57pp | 5.95%-4.47pp | 10.42%+7.66pp | 2.76%-6.38pp | 9.14%+1.19pp | 7.95% |
| EPS | 2.78-29.8% | 3.96-72.7% | 14.51+317.0% | 3.48-58.1% | 8.30+5.1% | 7.90 |
Corporate Events
Board MeetingBPLPHARMA
20265Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingBPLPHARMA
202512Nov
Board Meeting
Approved and took on record the Un-audited Standalone and Co…
BSE Filing ↗ Board MeetingBPLPHARMA
202429Oct
Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗ Board MeetingBPLPHARMA
202410Jun
Board Meeting
Consider and evaluate proposal for issue of Equity Shares on…
BSE Filing ↗ Board MeetingBPLPHARMA
202422May
Board Meeting
Consider and approve Audited Financial Results (Standalone &…
BSE Filing ↗ Board MeetingBPLPHARMA
202429Apr
Board Meeting
Consider and approve Intimation of Board Meeting, evaluate p…
BSE Filing ↗ Board MeetingBPLPHARMA
202413Feb
Board Meeting
Consider and Approve the Director's Report and secretarial A…
BSE Filing ↗ Board MeetingBPLPHARMA
20239Nov
Board Meeting
To consider and approve the unaudited financial results for …
BSE Filing ↗ Board MeetingBPLPHARMA
20239Aug
Board Meeting
Approval of Unaudited Financial Results for the Quarter ende…
BSE Filing ↗